Sign inJoin waitlistJoin the waitlist

Anishka D'Souza

Associate Program Director,#Hematology/Medical Oncology Fellowship#Program · University of Southern California/Los Angeles General Medical Center

Credentials: · · · · ·

History

#Hematology/Medical Oncology Fellowship#Program Fellowship · University of Southern California/Los Angeles General Medical Center
Present
University of Southern California/Los Angeles General Medical Center
Present

Hematology and Medical Oncology
University of Southern California/Los Angeles General Medical Center
2015–2018
Internal Medicine
Olive View/UCLA Medical Center
2012–2015
Doctor of Medicine
2008–2012

Research

Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
Nature Medicine · 2023 · 138 citations
Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study
The Lancet Oncology · 2023 · 81 citations
Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial
Gynecologic Oncology · 2020 · 59 citations

David Quinn
7 papers
Sia Daneshmand
7 papers
TD
Tanya Dorff
6 papers
Varsha Tulpule
6 papers · 1 as a fellow
Sumanta Pal
4 papers
Vinay Duddalwar
4 papers
Christos Kyriakopoulos
3 papers
CN
Craig Nichols
3 papers
Inderbir Gill
3 papers
JC
Jeremy Cetnar
3 papers
John Sfakianos
3 papers
Kevin Chan
3 papers

Clinical trials

Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer
Principal investigator · Active not recruiting · Phase 2
National Cancer Institute (NCI)
2018–2027
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
Site PI · Recruiting · Phase 3
University of Sydney
2014–2029